Compounds > mifepristone
Page last updated: 2024-08-23

mifepristone and Hyperplasia

mifepristone has been researched along with Hyperplasia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baldi, A; Cerliani, JP; Giulianelli, S; Gongora, A; Lamb, CE; Lanari, C; Molinolo, A; Sahores, A; Wargon, V1
Manyonda, I; Talaulikar, VS1
Chua, SS; DeMayo, FJ; Ma, ZQ; Ngan, ES; Tsai, SY1
Agarwal, R; Bhatia, N; Jiang, W; Thompson, HJ; Zhu, Z1
Aronovitz, M; Baur, WE; Conneely, O; Karas, RH; Kwoun, M; Lydon, JP; Mendelsohn, ME; O'Malley, BW; Roddy, S; van Eickels, M1
Delarue, F; el M'Selmi, A; Garel, JM; Jousset, V; Lacave, R; Peraldi, MN; Rondeau, E; Sraer, JD1

Reviews

1 review(s) available for mifepristone and Hyperplasia

ArticleYear
Progesterone and progesterone receptor modulators in the management of symptomatic uterine fibroids.
    European journal of obstetrics, gynecology, and reproductive biology, 2012, Volume: 165, Issue:2

    Topics: Endometrium; Estrenes; Female; Hormone Antagonists; Humans; Hyperplasia; Intrauterine Devices, Medicated; Leiomyoma; Levonorgestrel; Mifepristone; Norpregnadienes; Oximes; Receptors, Progesterone

2012

Other Studies

5 other study(ies) available for mifepristone and Hyperplasia

ArticleYear
Mifepristone inhibits MPA-and FGF2-induced mammary tumor growth but not FGF2-induced mammary hyperplasia.
    Medicina, 2010, Volume: 70, Issue:6

    Topics: Animals; Disease Models, Animal; Female; Fibroblast Growth Factor 2; Hormone Antagonists; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Medroxyprogesterone Acetate; Mice; Mifepristone

2010
Inducible expression of FGF-3 in mouse mammary gland.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Aug-20, Volume: 99, Issue:17

    Topics: Animals; Cell Adhesion Molecules; Disease Progression; Epithelial Cells; Female; Fibroblast Growth Factor 3; Fibroblast Growth Factors; Gene Expression Regulation, Developmental; Hyperplasia; Mammary Glands, Animal; Mammary Neoplasms, Animal; Mice; Mice, Transgenic; Mifepristone; Ovariectomy; Proto-Oncogene Proteins; Sexual Maturation

2002
Mechanisms of energy restriction: effects of corticosterone on cell growth, cell cycle machinery, and apoptosis.
    Cancer research, 2002, Sep-15, Volume: 62, Issue:18

    Topics: Animals; Cell Cycle; Cell Cycle Proteins; Cell Division; Corticosterone; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Energy Intake; Hyperplasia; Insulin-Like Growth Factor I; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Mifepristone; Proto-Oncogene Proteins; Tumor Suppressor Proteins

2002
A complex role for the progesterone receptor in the response to vascular injury.
    The Journal of clinical investigation, 2001, Volume: 108, Issue:4

    Topics: Animals; Carotid Artery Injuries; Carotid Artery, Common; Cell Division; Cells, Cultured; DNA Replication; Female; Hormone Antagonists; Hyperplasia; Mice; Mice, Knockout; Mifepristone; Muscle, Smooth, Vascular; Ovariectomy; Progesterone; Receptors, Progesterone; Recombinant Fusion Proteins; Transfection

2001
Dexamethasone increases preproparathyroid hormone messenger RNA in human hyperplastic parathyroid cells in vitro.
    European journal of clinical investigation, 1990, Volume: 20, Issue:4

    Topics: Amanitins; Binding, Competitive; Dexamethasone; Gene Expression Regulation; Humans; Hyperplasia; In Vitro Techniques; Mifepristone; Parathyroid Glands; Parathyroid Hormone; Protein Precursors; Receptors, Glucocorticoid; RNA, Messenger; Time Factors

1990